FDA Warns Of Overdose Risk For ENFit Syringes
Executive Summary
The US FDA issued a safety communication to patients and health care providers about the potential for overdose when using ENFit low dose tip syringes, and also told manufacturers to update labeling to account for the risk.
You may also be interested in...
FDA Posts Study Confirming OD Risk From ENFit LDT Syringes
The US FDA has posted a study affirming a safety communication the agency issued in October that warned of overdose risk from certain low dose tip syringes.
FDA Issues Guidance On Drugs Delivered Through Enteral Tubes
Recent draft guidance from the US agency provides recommendations for testing enteral feeding tubes, which are critical for those with difficulty swallowing or other digestive conditions or disabilities.
Alarming Rise Of Diabetes in Several US States, Study Shows
A study of diabetes rates across the US over four years reveals significant increases in the disease in many states. Tobias Oerum, diabetes advocate and cofounder of the company that conducted the study, discussed the data and some of the factors contributing to this troubling trend with Medtech Insight.